-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $12

Benzinga·08/14/2025 14:21:39
Listen to the news
Wells Fargo analyst Yanan Zhu maintains Metagenomi (NASDAQ:MGX) with a Overweight and lowers the price target from $16 to $12.